Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | GGT1 | P19440 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ARG1 | P05089 | 1/20 | 0.37 |
| ▸ | ARG2 | P78540 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23312 | 1.00 | — | — | |
| SCHEMBL29956233 | 1.00 | — | — | |
| SCHEMBL31421734 | 1.00 | — | — | |
| SCHEMBL11256487 | 1.00 | — | — | |
| Water SCHEMBL11216754 | 0.96 | — | — | |
| SCHEMBL8902015 | 0.96 | — | — | |
| SCHEMBL28212367 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1291178 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL159297 | 0.96 | — | — | |
| SCHEMBL15820259 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4201951-B1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023117904-A1 | METHOD FOR PEPTIDE SYNTHESIS | BACHEM HOLDING AG (CH) | 2023-06-29 | — | — | WO | disclosed |
| EP-4201951-A1 | METHOD FOR PEPTIDE SYNTHESIS | Bachem Holding AG (CH) | 2023-06-28 | — | — | EP | disclosed |
| EP-3658169-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Yeda Research and Development Co. Ltd (IL) | 2020-06-03 | — | — | EP | disclosed |
| WO-2019021284-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2019-01-31 | — | — | WO | disclosed |
| EP-3046929-A1 | ERK-DERIVED PEPTIDES AND USES THEREOF | Yeda Research and Development Co., Ltd. (IL) | 2016-07-27 | — | — | EP | disclosed |
| CN-103649019-B | Be used for the treatment of the 1-Piperazino-3-phenyl-indane of schizoid deuterate | H. LUNDBECK A/S (DK) | 2015-09-16 | — | — | CN | disclosed |
| WO-2015040609-A1 | ERK-DERIVED PEPTIDES AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-03-26 | — | — | WO | disclosed |
| CN-103649019-A | Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia | LUNDBECK & CO AS H | 2014-03-19 | — | — | CN | disclosed |
| US-8269037-B2 | Absorption medium for removing acid gases which comprises amino acid and acid promoter | BASF SE (DE) | 2012-09-18 | — | — | US | disclosed |
| US-20120051989-A1 | REMOVAL OF ACID GASES FROM A FLUID FLOW BY MEANS OF REDUCED COABSORPTION OF HYDROCARBONS AND OXYGEN | BASF SE (DE) | 2012-03-01 | — | — | US | disclosed |
| US-20120034364-A1 | USE OF PEPTIDES FOR IMPARTING KOKUMI | AJINOMOTO CO., INC. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2415359-A1 | USE OF PEPTIDE FOR IMPARTING BODY TASTE | Ajinomoto Co., Inc. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-8034166-B2 | Carbon dioxide absorbent requiring less regeneration energy | BASF SE (DE) | 2011-10-11 | — | — | US | disclosed |
| US-20100186590-A1 | ABSORPTION MEDIUM FOR REMOVING ACID GASES WHICH COMPRISES AMINO ACID AND ACID PROMOTER | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034364-A1 | USE OF PEPTIDES FOR IMPARTING KOKUMI | GIPR, GABRA6, GABRB1 | ALDH1A1 1964/4885TSHR 799/4885GGT1 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.